Alteration of liver enzymes is a feature of the Myh9-related disease syndrome

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Pecci, Alessandro ^a   Biino, Ginevra ^b   Fierro, Tiziana ^c   Bozzi, Valeria ^a   Mezzasoma, Annamaria ^c   Noris, Patrizia ^a   Ramenghi, Ugo ^d   Loffredo, Giuseppe ^e   Fabris, Fabrizio ^f   Momi, Stefania ^c   Magrini, Umberto ^a   Pirastu, Mario ^b   Savoia, Anna ^g   Balduini, Carlo ^a   Gresele, Paolo ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; MOLECULAR MOTOR; MYH9 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOGRAPHY; ELASTOGRAPHY; ENZYME DEFECT; ENZYME INDUCTION; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; ITALY; LAPAROSCOPY; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MYH9 RELATED DISEASE; THROMBOCYTE TRANSFUSION; BIOPSY; CASE CONTROL STUDY; DEMOGRAPHY; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; MULTIPLE MALFORMATION SYNDROME; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK; SYNDROME;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; ODDS RATIO; SYNDROME; YOUNG ADULT;

EID: 84865827218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035986     Document Type: Article

References (33)

1. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, et al. (2003) MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82: 203-15.
2. Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, et al. (2008) Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat 29: 409-17.
3. Kelley MJ, Jawien W, Ortel TL, Korczak JF (2000) Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 26: 106-8.
4. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, et al. (2000) Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet 26: 103-5.
5. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, et al. (2001) Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein and Alport-like syndromes. Am J Hum Genet 69: 1033-45.
6. Balduini CL, Pecci A, Savoia A (2011) Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol 154: 161-174.
7. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, et al. (2003) Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 83: 115-22.
8. Burt RA, Joseph JE, Milliken S, Collinge JE, Kile BT (2008) Description of a novel mutation leading to MYH9-related disease. Thromb Res 122: 861-3.
9. Savoia A, De Rocco D, Panza E, Bozzi V, Scandellari R, et al. (2010) Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost 103: 826-32.
10. Sellers JR (2000) Myosins: a diverse superfamily. Biochim Biophys Acta 1496: 3-22.
11. Jacobelli J, Chmura SA, Buxton DB, Davis MM, Krummel MF (2004) A single class II myosin modulates T cell motility and stopping, but not synapse formation. Nat Immunol 5: 531-8.
12. D'Apolito M, Guarnieri V, Boncristiano M, Zelante L, Savoia A (2002) Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes. Gene 286: 215-22.
13. Gershoni-Baruch R, Baruch Y, Viener A, Lichtig C (1988) Fechtner syndrome: clinical and genetic aspects. Am J Med Genet 31: 357-67.
14. Rocca B, Laghi F, Zini G, Maggiano N, Landolfi R (1993) Fechtner syndrome: report of a third family and literature review. Br J Haematol 85: 423-6.
15. Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, et al. (1999) Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13. Am J Hum Genet 65: 1711-7.
16. Biino G, Balduini C, Casula L, Cavallo P, Vaccargiu S, Parracciani D, et al. (2011) Analysis of 12517 inhabitants of a Sardinian geographic isolate reveals that propensity to develop mild thrombocytopenia during ageing and to present mild, transient thrombocytosis in youth are new genetic traits. Haematologica 96: 96-101.
17. Pecci A, Noris P, Invernizzi R, Savoia A, Seri M, et al. (2002) Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. Br J Haematol 17: 164-7.
18. Angius A, Melis PM, Morelli L, Petretto E, Casu G, et al. (2001) Archival, demographic and genetic studies define a Sardinian sub-isolate as a suitable model for mapping complex traits. Hum Genet 109: 198-209.
19. Savoia A, Balduini CL, Savino M, Noris P, Del Vecchio M, et al. (2001) Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 97: 1330-5.
20. Noris P, Perrotta S, Seri M, Pecci A, Gnan C, et al. (2011) Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 117: 6673-6680.
21. Gresele P, Falcinelli E, Giannini S, D'Adamo P, D'Eustacchio A, et al. (2009) Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. Haematologica 94: 663-9.
22. Balduini CL, Cattaneo M, Fabris F, Gresele P, Iolascon A, Pulcinelli FM, et al. (2003) Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 88: 582-92.
23. Noris P, Pecci A, Di Bari F, Di Stazio MT, Di Pumpo M, et al. (2004) Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. Haematologica 89: 1219-25.
24. Pecci A, Granata A, Fiore CE, Balduini CL. Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrol Dial Transplant 2008;23: 2690-2.
25. Tsukada N, Ackerley CA, Phillips MJ (1995) The structure and organization of the bile canalicular cytoskeleton with special reference to actin and actin-binding proteins. Hepatology 21: 1106-13.
26. Tsukada N, Azuma T, Phillips MJ (1994) Isolation of the bile canalicular actin-myosin II motor. Proc Natl Acad Sci U S A 91: 6919-23.
27. Watanabe S, Miyazaki A, Hirose M, Takeuchi M, Ohide H, et al. (1991) Myosin in hepatocytes is essential for bile canalicular contraction. Liver 11: 185-9.
28. Subramanian VS, Marchant JS, Said HM (2010) Molecular determinants dictating cell surface expression of the human sodium-dependent vitamin C transporter-2 in human liver cells. Am J Physiol Gastrointest Liver Physiol 298: G267-74.
29. Chan W, Calderon G, Swift AL, Moseley J, Li S, et al. (2005) Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-Darby canine kidney cells. J Biol Chem 280: 23741-7.
30. Margall-Ducos G, Celton-Morizur S, Couton D, Brégerie O, Desdouets C (2007) Liver tetraploidization is controlled by a new process of incomplete cytokinesis. J Cell Sci 120: 3633-9.
31. Herrema H, Czajkowska D, Théard D, van der Wouden JM, Kalicharan D, et al. (2006) Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells. Mol Biol Cell 17: 3291-303.
32. Bhadriraju K, Hansen LK (2004) Extracellular matrix-dependent myosin dynamics during G1-S phase cell cycle progression in hepatocytes. Exp Cell Res 300: 259-71.
33. Török N, Urrutia R, Nakamura T, McNiven MA (1996) Upregulation of molecular motor-encoding genes during hepatocyte growth factor- and epidermal growth factor-induced cell motility. J Cell Physiol 167: 422-33.